Loading...
Market
Who will be the next CEO of 23andMe if Anne Wojcicki steps down by the end of 2024?
3
Resolution / Starting Odds
Current CFO Steve Schoch • 25%
Current COO Frances Frei • 25%
External Candidate • 25%
Other • 25%
Official company announcements and major financial news outlets
Story
Seven 23andMe Board Members Resign Effective Immediately Over CEO's Privatization Plan
Sep 18, 2024, 02:49 PM
All seven independent directors of 23andMe have resigned from the company's board, effective immediately, citing dissatisfaction with CEO Anne Wojcicki's proposal to take the company private. The directors expressed frustration over the lack of progress on Wojcicki's buyout plan, which had been delayed for five months. This mass resignation follows the rejection of an incomplete offer in August and leaves Wojcicki as the sole remaining board member. Despite the board's departure, Wojcicki remains committed to her privatization plan. The resignations come shortly after 23andMe settled a genetic privacy lawsuit for $30 million. The company's stock is down 95% since going public, and Wojcicki stated she was 'surprised and disappointed' by the resignations.
View original story
Similar markets
Internal promotion • 25%
External hire • 25%
No new CEO appointed • 25%
Anne Wojcicki remains CEO • 25%
New CEO appointed from within the company • 25%
New CEO appointed from outside the company • 25%
Interim CEO appointed • 25%
Anne Wojcicki remains CEO • 25%
New CEO appointed from internal candidate • 25%
New CEO appointed from external candidate • 25%
Interim CEO appointed • 25%
Successful privatization • 25%
Abandoned privatization • 25%
New buyout offer • 25%
Other outcome • 25%
Yes • 50%
No • 50%
Accepted as is • 25%
Revised and accepted • 25%
Rejected • 25%
Withdrawn • 25%
Successful privatization • 25%
Abandoned privatization plan • 25%
Privatization plan still in progress • 25%
Other outcome • 25%
CEO steps down • 25%
CFO steps down • 25%
Both step down • 25%
No change • 25%